Unigene Laboratories, Inc. to Present at the Rodman & Renshaw Annual Global Investment Conference on September 12, 2011

BOONTON, N.J.--(BUSINESS WIRE)--Unigene Laboratories, Inc. (OTCBB: UGNE) a leader in the design, delivery, manufacture and development of peptide-based therapeutics announced today that Ashleigh Palmer, President and Chief Executive Officer will be presenting a corporate overview at the Rodman & Renshaw Annual Global Investment Conference. Mr. Palmer’s live presentation is scheduled to begin at 10:25 a.m. ET on Monday, September 12, 2011.

MORE ON THIS TOPIC